These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Allogeneic bone marrow transplantation for Gaucher disease--a case report. Yen CC; Chiou TJ; Lin CY; Wang NH; Chen PM Zhonghua Yi Xue Za Zhi (Taipei); 1997 Jun; 59(6):372-6. PubMed ID: 9294918 [TBL] [Abstract][Full Text] [Related]
11. [Gaucher's disease; current developments in the treatment of lysosomal metabolic disease]. Hollak CE; Aerts JM; Goudsmit R Ned Tijdschr Geneeskd; 1991 Nov; 135(46):2162-4. PubMed ID: 1956441 [No Abstract] [Full Text] [Related]
13. [Gaucher disease: diagnosis and treatment]. Fumić K; Stavljenić-Rukavina A; Mrsić M; Potocki K Acta Med Croatica; 2004; 58(5):353-8. PubMed ID: 15756799 [TBL] [Abstract][Full Text] [Related]
14. Enzymic differentiation of neurologic and nonneurologic forms of Gaucher's disease. Glew RH; Daniels LB; Clark LS; Hoyer SW J Neuropathol Exp Neurol; 1982 Nov; 41(6):630-41. PubMed ID: 6813430 [TBL] [Abstract][Full Text] [Related]
15. Gene transfer and bone marrow transplantation with special reference to Gaucher's disease. Karlsson S; Correll PH; Xu L Bone Marrow Transplant; 1993; 11 Suppl 1():124-7. PubMed ID: 8448536 [TBL] [Abstract][Full Text] [Related]
16. The presence of an autologous marrow stromal cell layer increases glucocerebrosidase gene transduction of long-term culture initiating cells (LTCICs) from the bone marrow of a patient with Gaucher disease. Wells S; Malik P; Pensiero M; Kohn DB; Nolta JA Gene Ther; 1995 Oct; 2(8):512-20. PubMed ID: 8593601 [TBL] [Abstract][Full Text] [Related]
17. Gaucher's disease. Enzyme therapy is not enough. Grabowski GA Lancet; 2001 Dec; 358 Suppl():S29. PubMed ID: 11784578 [No Abstract] [Full Text] [Related]
18. Bone marrow transplantation from a cadaveric donor. Kapelushnik J; Aker M; Pugatsch T; Samuel S; Slavin S Bone Marrow Transplant; 1998 Apr; 21(8):857-8. PubMed ID: 9603417 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic delivery of proteins to macrophages: implications for treatment of Gaucher's disease. Mistry PK; Wraight EP; Cox TM Lancet; 1996 Dec; 348(9041):1555-9. PubMed ID: 8950883 [TBL] [Abstract][Full Text] [Related]
20. Marked clinical and histologic improvement in a patient with type-1 Gaucher's disease following long-term glucocerebroside substitution. A case report and review of current diagnosis and management. Heukamp LC; Schröder DW; Plassmann D; Homann J; Büttner R Pathol Res Pract; 2003; 199(3):159-63. PubMed ID: 12812317 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]